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CENTRAL VENOUS ACCESS SYSTEM
CROSS REFERENCE TO RELATED CASES
The present application is a division of U.S. patent
application Ser. No. 12/958,702 filed Dec. 2, 2010, which
claims the benefit of both U.S. Provisional Application
61/363,436 entitled "CENTRAL VENOUS ACCESS
METHOD, SYSTEM and DEVICES" filed 12 Jul. 2010;
and U.S. Provisional Application 61/266,298 entitled
"INSIDE/OUT CENTRAL VENOUS ACCESS and APPARATUS" filed 3 Dec. 2009. The entire contents of each of
the above-referenced disclosures are specifically incorporated herein by reference without disclaimer.
BACKGROUND OF THE INVENTION
Central venous access (CVA) is one of the most commonly performed procedures in medicine. CVA is vital to
many patients with acute and chronic illness. Hemodialysis
and cardiac pacing are examples of life-sustaining therapies
that would not be possible without central venous access.
CVA is typically obtained by using a large gauge needle
to directly puncture first the skin and then one of the four
large upper body veins, for example, the right or left internal
jugular vein, or the right or left subclavian vein. After
puncture, a guidewire is introduced through the needle and
advanced into the central circulation. The channel is then
dilated and a catheter or other medical device is advanced
into the superior vena cava (SVC) or right atrium (RA).
Although central venous access is usually a straightforward procedure, there can be both short term and long term
complications. Immediate risks include bleeding due to
inadvertent puncture of carotid or subclavian arteries, and
pneumothorax due to unintended puncture of a lung. These
complications occur because central veins lie deep beneath
the skin and are therefore not visible to the operator. As a
result, there is often uncertainty about the location, depth
and entry angle of the puncture needle, even when ultrasound guidance is used. The long-term risks of central
access include venous occlusion, which can occur within
days and is a common problem in patients requiring
repeated access or semi-permanent access. Chronic
venous occlu-sions occur when thrombus forms around
a catheter or pacing lead, and then organizes into dense
fibrous tissue that permanently obliterates the vessel lumen.
When confronted with occlusion of a central vein, physicians usually utilize one of the remaining veins in the
upper body. The process can continue until all four central
veins have been obliterated. However, once all four upper
body central veins are lost the patient can have a life
threatening access crisis.
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SUMMARY OF THE INVENTION
The method is carried out by intravascular navigation of
a catheter system that includes specialized devices serving
multiple functions. An exit point target site is identified for
example near the clavicle on the exterior of the patient's
body. The specialized set of intravascular devices in the
catheter system are navigated from a remote entry point for
example, in the groin to a position proximate the desired exit
point target site. A very sharp needle wire is pushed through
the catheter system and is directed by the catheter system in
a defined and desired direction. Passage of this needle wire
forms an extra-vascular tissue track from the vessel to the
skin near the exit point target site.

2

With the needle wire pushed through the skin and exteriorized, companion devices are pushed and/or pulled
through the tissue track enlarging it and preparing it for the
placement of an access port or pacing lead or the like. The
combination of pushing and pulling motions enabled by the
catheter system allows for the safe and quick access or
re-acquisition of a lost access site to the central venous
system. In many instances the ability to work close to
thrombus and near occlusions with great precision allows
the recovery or salvage of an otherwise lost venous access
location, which is a si g n if icant benefit to the patient.

55

In the several fi g u res of the drawings, identical reference
numerals are used to identify identical or equivalent structure wherein:
FIG. 1 is a schematic diagram showing a portion of the
venous system of a patient;
FIG. 2A is a plan view schematic diagram showing the
use of a catheter system to access the central venous system;
FIG. 2B is a cross-sectional schematic diagram
showing a side view of the system of FIG. 2A;
FIG. 3 is a schematic representation of the distal ends of
elements of the catheter system;
FIG. 4 is a schematic diagram showing an assembly of the
proximal ends of the catheter system;
FIG. 5 is a schematic depiction of a step in the process and
illustrates the function of an element of the catheter system;
FIG. 6 is a schematic depiction of a step in the process and
illustrates the function of an element of the catheter system;
FIG. 7 is a schematic depiction of a step in the process and
illustrates the function of an element of the catheter system;
FIG. 8 is a schematic depiction of a step in the process and
illustrates the function of an element of the catheter system;
FIG. 9 is a schematic depiction of a step in the process and
illustrates the function of an element of the catheter system;
FIG. 10 is a schematic depiction of a step in the process
and illustrates the function of an element of the catheter
system;
FIG. 11 is a schematic depiction of a step in the process
and illustrates the function of an element of the catheter
system;
FIG. 12 is a schematic depiction of a step in the process
and illustrates the function of an element of the catheter
system;
FIG. 13 is a schematic depiction of a step in the process
and illustrates the function of an element of the catheter
system;
FIG. 14 is a schematic depiction of a step in the process
and illustrates the function of an element of the catheter
system, and;
FIG. 15 is a schematic depiction of a step in the process
and illustrates the function of an element of the catheter
system.
DETAILED DESCRIPTION OF THE
INVENTION

60

65

One of the most clinically significant uses of the devices
and methods of this invention pertains to right-sided supraclavicular access because it combines the preferred location
for long-term catheters, the most common site of chronic
venous occlusions, and the most straightforward application
of the invention. Therefore this procedure has been selected
as an illustrative but not limiting example of the techniques
and suitable hardware implementations of the catheter sys-
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4

tern invention. The invention is illustrated in the context of
FIG. 3 shows the distal tips of various elements of the
catheter system assembled in various configurations or coma patient having an occluded right internal jugular vein
binations in several panels. The relatively long rigid guide
which is recovered by use of the method and catheter system
catheter work station 30 can support various devices within
to place a new access point near the one lost to the occlusion.
its working lumen 31. It is expected that suitable perforIn contrast to the conventional practice that would sacrifice
mance can be achieved by manufacturing the rigid guide
companion vessels, the illustration achieves re-entry very
catheter 30 with conventional techniques well known in the
near a lost CVA location.
art in a diameter of about SF permitting the device to
FIG. 1 shows the context of the invention and presents the
delivered through an SF introducer. Both metal and braided
interventional path with respect to certain anatomic reference points. FIG. 2A and FIG. 2B should be considered 10 structures are expected to be suitable.
together and together they show the placement of the rigid
In the figure the dilation stylet 42 is shown within the
guide catheter work station with regard to preferred analumen 31 of the rigid guide catheter work station 30. The
tomic reference points. FIG. 2A also shows the proximal end
dilation stylet 42 is free to move within the lumen 31.
portions of elements of the catheter system extending out of 15 Depending on the point in procedure, the central working
the patient's body. FIG. 3 shows the distal end portions of
lumen 43 of the dilation stylet 42 may carry and support
catheter system elements. FIG. 4 shows the proximal ends of
either the canalization wire 48 or the needle wire directional
catheter systems elements. The intermediate portions of the
guide 40. The needle wire directional guide 40 has a central
catheter elements are not shown for clarity but they should
lumen 41 adapted to receive the needle wire 46. The distal
be understood to continue from the distal to the proximal 20 tip of the needle wire 46 is quite sharp and acts like a trocar
ends and have overall lengths suitable for the size of the
to cut and divide tissue as it is pushed. The stiffness of the
patient, and will be on the order of 200 cm overall or more
device and its sharpness must be selected so that it can be
for an adult case. FIG. 5 through FIG. 15 depicts steps in an
pushed through tissue. A sharpened nitinol. 014 wire has
approximately the correct properties for the needle wire.
illustrative fashion of a method of using the catheter system.
FIG. 1 shows a patient 10 with an occluded right internal 25 Note as well that the distal tip of the needle wire directional
guide 40 forms a gentle curve 47 to direct and deflect the
jugular vein indicated by the cross-hatched occlusion in the
needle wire 46 in a specific direction. It is expected that this
vessel at reference numeral 12. The method and devices of
portion of the device will be manufactured from a shape
the invention are used to re-acquire access to the central
memory material such as nitinol, with the gentle curve 47
venous system through an exit point target location 16 near
and slightly above the collar bone or clavicle 14. Beginning 30 formed where the needle wire directional guide 40 emerges
from the distal tip of the dilation stylet 42. The gentle curve
at a remote entry point 18 near a large femoral vein in the
will direct the needle wire through an angle near 90 degrees
groin of the patient, the interventional path is seen as a
or so.
dashed line at reference numeral 20. In practice the surgeon
FIG. 4 shows the proximal ends of some of the compowill use conventional techniques to enter the femoral vein
then introduce the inventive catheter system and use it to 35 nents assembled into working configurations. In general, the
follow the interventional path 20 forming an exit through the
rigid guide catheter work station 30 is placed at the correct
skin of the body near the clavicle at the exit point 16 in this
location previously described and it remains largely stationillustrative description. Once an appropriate tissue track is
ary once positioned. An associated valve and flush port with
established between the exit location 16 and the central
Luer fittings is provided to introduce fluids to clear the
venous system the tissue track will be prepared for the 40 devices and occasionally introduce contrast agent. The
delivery of a conventional CVA access port or other device
hemostasis valve and flush valve are shown schematically
labeled 37 in the figure. Operation and configuration will be
concluding the access procedure.
described in more detail in the steps of the method.
FIG. 2A is a schematic illustration depicting the placement of the rigid guide catheter work station 30 placed along
FIG. 5 shows a step in the method. As a prelude to this
the interventional path with the distal tip 33 of the work 45 step the entry and exit points on the skin of the patient will
station located above the right atrium 32 at about the level
be identified and perhaps marked. Next the vascualture will
of the ostium of the azygos vein seen at 36. The exit target
have been accessed via a conventional Seldinger procedure.
At his time the rigid guide catheter work station 30 is
location is shown at 16 and the remote entry point is shown
introduced over a wire into the venous circulation. The
at 18. Proximal portions of the catheter system extend out of
the groin area and they are collectively labeled 17. The 50 straightness of the vasculature and the straightness of the
physician manipulates these proximal ends of elements of
rigid guide catheter workstation 30 allow for navigation,
the catheter system rotating, retracting and advancing them
indicated by arrow 51, of the distal end of the catheter
to navigate through the vasculature, while observing the
workstation 30 to the preferred location in the figure above
locations of the distal ends of the devices under fluoroscopy.
the right atrium RA 32, below the occlusion 12 and near the
FIG. 2B is a schematic cross section of the patient with 55 clavicle 14.
FIG. 6 shows a step in the method. Next the dilation sty let
anatomic landmarks called out in the figure showing the
42 is advanced out of the rigid catheter work station with the
placement of the rigid guide catheter work station 30, and is
needle wire directional guide 40 to about the occlusion 12
a side view of FIG. 2A. The figure shows successful
which is typically verified with a contrast injection. The
deflection anteriorly of the rigid guide catheter work station
30 at the junction of the IVC and RA 32. This places the 60 physician manipulating the directional guide arm 45 aims
the needle wire directional guide 40 so that the exit port
60distal tip 33 ofthe workstation against the anterior wall of
lumen 41 points toward the exit location target site 16
the SVC. This forces or biases the distal tip 33 against the
identified on the skin of the patient. Although it is difficult
wall of the vessel and also protects posterior structures from
to illustrate the placement of the rigid guide catheter work
involvement with the catheter system. Once this placement is
achieved the work station 30 remains relatively stationary 65 station 30 it is placed along the anterior wall of the SVC so
that the needle wire guide 40 and dilation stylet 42 can be
during the rest of the procedure until it is ultimately removed
from the body.
advanced safely toward the occlusion without interfering
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with other structures. At this point the needle wire directional guide port or lumen 41 is a short distance from the
target exit point 16.
FIG. 7 shows a step in the method. With aiming completed the physician can push the wire clamp 50 (FIG. 4) to
advance the needle wire 46 out of the lumen 41 of the needle
wire directional guide 40 and dissect a tissue path toward the
clavicle as indicated by force and motion arrow 53 defining
an extra vascular tissue track. The rigidity of the rigid
catheter work station 30 and its placement allow the reaction
forces from the needle wire 46 advancement to be taken up
the rigid guide catheter work station and dilation stylet 42
and transferred to the body. The cross section of FIG. 28
also depicts this step with the needle wire 46 actually
exteriorized in that figure.
FIG. 8 shows a step in the method. The physician continues to advance the needle wire 46 until it becomes
exteriorized at the exit point 16. The small wound depicted
at reference numeral 60 indicates the exit point. The needle
wire 46 segment labeled 62 lies outside the body.
FIG. 9 shows a step in the method. The physician will
next clamp the needle wire 46 to the dilation stylet 42 with
a wire clamp 50 or similar device at the proximal ends of the
devices as depicted in FIG. 4. and apply traction to the
exterior segment of the needle wire 62 pulling the dilation
stylet 42 out of the body through the exit point enlarging the
tissue track created by the passage of the needle wire 46.
FIG. 10 shows a step in the method. The physician may
next remove the needle wire 46 and the needle wire directional guide 40 leaving the dilation stylet exteriorized and its
central lumen 43 empty.
FIG. 11 shows a step in the method. With the dilation
sty let 42 exposed outside the patient the physician may then
load or backload a larger gauge wire such as a canalization
wire 48 or other guide wire product into the lumen of the
dilation stylet. This larger diameter wire will support the
next stages of the intervention. The wire size and type is
driven mostly by the device that is to be implanted. In the
illustrative process a CVA dialysis type port is to be
implanted using a conventional introducer sheath 64.
FIG. 12 shows a step in the method. The physician may
load the conventional introducer sheath 64 onto the canalization wire 48 and clamp them together with a wire clamp
50 or the like. The physician has a choice of pulling the
introducer along the extra vascular tissue track by tugging
on the proximal portions of the dilation stylet and canalization wire or pushing it along the tissue track from the distal
end of the system or doing both sequentially or simultaneously.
FIG. 13 shows a step in the method. This figure shows the
introducer sheath 64 placed into the central venous system
just below the level of the occlusions thus salvaging the
location. This figure shows the introducer 64 in place and the
physician may remove the rigid guide catheter workstation
and related devices from the femoral entry point. The
physician may leave a guide wire in place depending on the
course of the procedure.
FIG. 14 shows a step in the method. The physician may
access the lumen of the convention al introducer 64 to permit
the insertion of the dialysis port 66, though the lumen of the
introducer. The precise sequence and hemostasis management will depend on the particularities of the port and the
introducer and is not part of the invention apart from
illustrating the utility of the procedure.
FIG. 15 shows a dialysis port 66 placed in the patient via
the catheter system and method. This port lies in a desirable
location that would have been otherwise lost.
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The method and suite of devices that make up the catheter
system can be used to acquire or re-acquire CVA allowing
for the salvage or reuse of vessels and locations that are lost
to conventional methods and devices. The method is dependent upon the use of particular devices having specific
qualities. The rigid guide catheter work station must be stiff
enough to resist reaction forces supplied by the needle wire
as it dissects tissue and establishes the tissue track. The
needle wire must be stiff enough to dissect tissue when
pushed from its proximal end. It must be stiff enough to not
wander off course and a very sharp trocar like tip aids in
minimizing the force required for dissection. The needle
wire directional guide must not whip or kink while it is being
aimed under X-ray guidance.
It is also noted that there is much flexibility in the
procedure and the system and apparatus used to carry out the
method. Some variation in the method will reflect operator
preference or the state or size of the patient. For this reason
the descriptions herein are intended to be illustrative and not
limiting. In a similar fashion the set of specialized medical
devices illustrated for carrying out the invention can be
supplemented or truncated and certain functions can be
carried out with alternate devices. As a consequence the
description of the favored hardware should be considered
illustrative and not limiting.
What is claimed is:
1. A method for acquiring access to the central venous
system of a patient at a target location near an occlusion of
a jugular vein, comprising the steps of:
introducing a guide catheter into a blood vessel at a
location remote from said occlusion;
advancing a needle wire having a sharp end transvascularly through the guide catheter until its sharp end is
adjacent the occlusion;
rotationally adjusting said needle wire until its sharp end
is aimed toward the desired skin exit location;
advancing the needle wire to puncture the blood vessel
from the inside out at a vascular exit site adjacent the
occlusion, thereby establishing a tissue track;
further advancing the needle wire along said tissue track
thereby extending said tissue track to puncture the skin
from the inside out near said vascular exit site.
2. The method of claim 1 further including the steps of:
enlarging said tissue track by sequential dilation.
3. The method of claim 2 wherein said enlarging step
includes;
clamping said needle wire and said dilation sty let together
and drawing them together from said target location.
4. A method for acquiring access to the central venous
system of a patient near an occlusion, comprising the steps
of:
identifying an exit point target site on the exterior skin of
a patient near an occlusion;
introducing a needle wire having a sha r p end into a blood
vessel at a location remote from said occlusion;
advancing the needle wire through the vascalature until its
sharp end is adjacent the occlusion;
aiming the sharp end of the needle wire toward the exit
point target; and
advancing the needle wire through the occlusion and
through the blood vessel until it becomes exteriorized
at the exit point target to establish a tissue track from
the blood vessel to the exterior of the patient.
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5. The method of claim 4, further comprising introducing
a guide catheter with a lumen into the patient at the location
remote from the patient and advancing the guide catheter to
the occlusion.
6. The method of claim 5, comprising advancing a dilation
stylet through the guide catheter to the occlusion, the dilation stylet having a lumen for receiving the needle wire.
7. The method of claim 6, further comprising pulling the
dilation stylet out of the body through the exit point to
enlarge the tissue track created by the needle wire.
8. The method of claim 6, wherein the step of aiming the
sharp end of the needle wire comprises rotating the dilation
sty let.
9. A method for acquiring access to the central venous
system of a patient near an occlusion, comprising the steps
of:
identifying an exit point target site on the exterior skin of
a patient near an occlusion;
introducing a guide catheter having a first lumen into a
blood vessel at a location remote from the exit point
target site and advancing the guide catheter to the
occlusion;

10
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advancing a dilation sty let having a second lumen through
the guide catheter lumen to the occlusion; advancing a
needle wire with a sharpened end through the
dilation stylet lumen so that the sharpened end is
adjacent the occlusion;
aiming the sharp end of the needle wire toward the exit
point target; and
advancing the needle wire through the occlusion and
through the blood vessel until it becomes exteriorized
at the exit point target to establish a tissue track from
the blood vessel to the exterior of the patient.
10. The method of claim 9, wherein the remote site
comprises a femoral vein in a groin of the patient.
11. The method of claim 9, further comprising placing an
introducer sheath in the tissue track.
12. The method of claim 9, further comprising pulling the
dilation stylet out of the body through the exit point to
enlarge the tissue track created by the needle wire.
13. The method of claim 12, further comprising introducing a canalization wire into the dilation stylet.
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